Singapore, Singapore

Cheng Hsia Angeline Lee

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Sinagpore, SG (2015)
  • Singapore, SG (2012 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Cheng Hsia Angeline Lee

Introduction

Cheng Hsia Angeline Lee, a distinguished inventor based in Singapore, has made significant contributions to the field of pharmaceuticals, specifically through his innovative work on pyrimidine compounds. With a total of seven patents to his name, he stands out in the realm of intellectual property and invention.

Latest Patents

One of his recent inventions includes the development of oxygen-linked pyrimidine derivatives. This groundbreaking work focuses on pyrimidine compounds that serve as anti-proliferative agents. Lee's innovations relate to both the preparation and use of these compounds in treating proliferative disorders, making strides in therapeutic options for tumors and cancers, as well as other kinase-related conditions.

Another notable patent is centered around the citrate salt of a complex compound named 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene. This invention highlights improved properties and includes pharmaceutical compositions that can be used in treating various medical conditions, showcasing Lee’s commitment to advancing medicinal science.

Career Highlights

Throughout his career, Cheng Hsia Angeline Lee has held significant positions at prominent companies, including S*bio Pte Ltd and CTI BioPharma Corp. His work in these establishments has been instrumental in pushing the boundaries of pharmaceutical research and development.

Collaborations

Lee has collaborated with various experts in the field, including Anthony Deodaunia William and Harish Kumar Mysore Nagaraj. These partnerships reflect his dedication to collaborative innovation, which often leads to more refined and effective therapeutic solutions.

Conclusion

Cheng Hsia Angeline Lee exemplifies the spirit of innovation in the pharmaceutical industry. His impressive array of patents and collaborative efforts with peers are a testament to his expertise and vision. As he continues to contribute to groundbreaking research, his work promises to have a lasting impact on medicine and the treatment of critical health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…